First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States

BACKGROUND: Various therapeutic strategies are available for the first-line treatment of patients with advanced hepatocellular carcinoma (aHCC). But which approach is the most cost-effective remains uncertain. OBJECTIVES: This study aims to evaluate the cost-effectiveness of first-line strategies in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ke-Xin, Cao, Shan-Shan, Shi, Feng-Hao, Guan, Yue, Tang, Meng, Zhao, Mei-na, Jian, Yu-Fan, Cui, Bin, Li, Zhi-Yan, Wang, Jing-Wen, Yu, Feng, Ding, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742927/
https://www.ncbi.nlm.nih.gov/pubmed/36518883
http://dx.doi.org/10.1177/17562848221140662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742927/
https://www.ncbi.nlm.nih.gov/pubmed/36518883
http://dx.doi.org/10.1177/17562848221140662

Ejemplares similares